Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia [Phase 2]

View source ↗

Summary

Phase II clinical trial of CMS-D002 Capsule for uterine fibroids with menorrhagia is currently recruiting. The sponsor is Shenzhen Kangzhe Biotechnology Co., Lt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CMS-D002 Capsule

Snippet

Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. | Conditions: Uterine Fibroids With Menorrhagia | Phase 2 | Status: RECRUITING